Quantcast
Home > Quotes > AQST

Aquestive Therapeutics, Inc. Common Stock (AQST) Quote & Summary Data

AQST 
$3.94
*  
0.26
6.19%
Get AQST Alerts
*Delayed - data as of Jun. 26, 2019  -  Find a broker to begin trading AQST now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 4.25 / $ 3.90
Share Volume
133,394
50 Day Avg. Daily Volume
117,501
Previous Close
$ 4.20
52 Week High / Low
$ 20.6961 / $ 3.65
Market Cap
98,402,048
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
133,394
50 Day Avg. Daily Volume:
117,501

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -3.69

Trading Range

The current last sale of $3.94 is 7.95% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 4.25 $ 20.6961
 Low: $ 3.90 $ 3.65

Company Description (as filed with the SEC)

Aquestive Therapeutics, Inc. a Delaware corporation, was formed effective on January 1, 2018 via the conversion of MonoSol Rx, LLC, a Delaware limited liability company and predecessor or Aquestive Therapeutics, Inc., into a C corporation and a simultaneous name change to Aquestive Therapeutics, Inc. (referred to in this Annual Report on Form 10-K as the "January Conversion"). Unless the context otherwise indicates, references to "Aquestive", "AQST", "we", the "Company", "us" and "our" in this Annual Report on Form 10-K refers to Aquestive Therapeutics, Inc. Our principal executive offices are located in Warren, New Jersey. Overview We are a specialty pharmaceutical company focused on developing and commercializing differentiated products to address unmet medical needs. We have a late-stage proprietary product pipeline focused on the treatment of diseases of the Central Nervous System, or CNS.  ... More ...  



Risk Grade

Where does AQST fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 4.22
Open Date:
Jun. 26, 2019
Close Price:
$ 3.94
Close Date:
Jun. 26, 2019


Consensus Recommendation

Analyst Info